Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (2)
  • 2024 (2)
  • 2023 (4)
  • 2022 (4)
  • 2021 (7)

Subject

  • Prescription Drugs (59)
  • Drug Trafficking (49)
  • Pharmaceuticals/Pharmacists/Physicians (48)
  • Diversion Division (43)
  • Synthetic drugs (39)
  • Seizures (Drugs/Property) (34)
  • Task Forces/Task Force Officers (27)
  • Major Law Enforcement Operation (17)
  • Outreach/Drug Prevention (17)
  • Arrests/Convictions - Major (14)
  • OCDETF/Task Force (14)
  • Fake Pills (13)
  • Guilty Plea (12)
  • Guns/Weapons (10)
  • One Pill Can Kill (7)
  • Prevention/Education - DEA websites GSAD, JTT etc (7)
  • Press Conferences (6)
  • Fentanyl Awareness (5)
  • Take Back Day (4)
  • Public and Media Affairs - also see Congressional Affairs (3)
  • Dark Web- Internet Trafficking (2)
  • Gangs (2)
  • Intelligence Division - Intelligence Products (1)
  • Money Laundering (1)
  • Museum and Visitors Center (1)
  • Narcoterrorism (1)
  • Overdose (19)

Drug Name

  • Fentanyl (218)
  • Heroin (48)
  • Cocaine (39)
  • Synthetic Opioids (25)
  • Methamphetamine (23)
  • Oxycodone (14)
  • Marijuana (Cannabis) (6)
  • Benzodiazepines (3)
  • Hydromorphone (3)
  • Ecstasy/MDMA (2)
  • K2/Spice (2)
  • Marijuana Concentrates (2)
  • Morphine (2)
  • Methadone (1)
  • Synthetic Bath Salts or Designer Cathinones (1)
  • Xylazine (1)
  • Opioids (16)
  • Ketamine (3)

Field Division

  • Washington, DC (15)
  • Dallas (1)
  • Los Angeles (1)
  • New York (1)
  • St. Louis (1)
Clear All Results
PRESS RELEASE

North Hollywood Woman Agrees to Plead Guilty to Federal Drug Charges, Including Selling Ketamine that Killed Actor Matthew Perry

Agosto 19, 2025
LOS ANGELES – A San Fernando Valley woman has agreed to plead guilty to five federal criminal charges, including that she provided the ketamine that ultimately resulted in the overdose death of actor Matthew Perry in October 2023, the Justice Department announced on Monday. Jasveen Sangha, 42, a.k.a. “Ketamine Queen,”...
Agosto 19, 2025
PRESS RELEASE

15-Year Prison Sentence for Deadly Drug Deal that Killed Two People

Junio 27, 2025
WASHINGTON – Jevaughn Mark, 33, of Washington D.C., was sentenced today in U.S. District Court to 180 months in federal prison for running a prolific drug delivery service in the metropolitan area and included the December 2023 sale of fentanyl he sold as “ketamine” that resulted in the deaths of...
Junio 27, 2025
PRESS RELEASE

U.S. Attorney’s Office and DEA Announce Fatal Fentanyl Overdose Task Force

Octubre 28, 2024
Baltimore, Maryland – Erek L. Barron, U.S. Attorney for the District of Maryland and Jarod Forget, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) Washington Division, announced that their agencies have formed the Maryland Fatal Fentanyl Overdose Task Force (“MFFOTF”). The alarming rate of overdoses in Maryland has...
Octubre 28, 2024
PRESS RELEASE

Nassau Doctor Sentenced to Up to 15 Years in Prison for Overprescription of Opioids that Led to Five Deaths

Enero 22, 2024
MINEOLA, N.Y. – Nassau County District Attorney Anne T. Donnelly announced today that a Nassau County doctor has been sentenced to up to 15 years in prison for prescription practices that led to the deaths of five patients between 2016 and 2018. George Blatti, 78, pleaded guilty on October 10...
Enero 22, 2024
PRESS RELEASE

DEA Washington Division Holds Second Annual Family Summit on Fentanyl

Octubre 13, 2023
WASHINGTON, DC – On October 6, the Drug Enforcement Administration (DEA) Washington Division hosted their 2nd Family Summit in support of those who have lost loved ones to fentanyl poisoning in the District of Columbia, Maryland, and Virginia. The Summit was very emotional and educational to all those who attended...
Octubre 13, 2023
PRESS RELEASE

Consent Decree Approved Among the U.S. and Cumberland, M.D. based Pharmacy and Pharmacist

Julio 06, 2023
Baltimore, Maryland - U.S. District Judge Lydia K. Griggsby approved the United States’ consent decree with John A. Beckman, a Cumberland, Maryland based pharmacist, and Beckman’s Greene Street Pharmacy, Inc. (“Beckman’s Pharmacy”), resolving the United States’ civil allegations that Beckman and Beckman’s Pharmacy violated the Controlled Substances Act (“CSA”) in...
Julio 06, 2023
PRESS RELEASE

Federal Jury Convicts St. Louis County Man of Dealing Fatal Dose of Heroin and Fentanyl

Mayo 05, 2023
ST. LOUIS – A jury in U.S. District Court in St. Louis on Thursday found a convicted felon guilty of selling the heroin and fentanyl that killed a Florissant, Missouri, man in 2018. The jury found Wyland Kinney, 43, of St. Louis County, guilty of four felony counts: distribution of...
Mayo 05, 2023
PRESS RELEASE

DEA Washington Division Announces the Seizure of Over 8 Million of Deadly Doses of Fentanyl in 2022

Enero 26, 2023
Washington DC – The Drug Enforcement Administration’s (DEA) Washington Division seized over 8.3 million potentially deadly doses of fentanyl in 2022. The division, which covers the District of Columbia, Maryland and Virginia confiscated nearly 160,000 fake pills containing fentanyl, and more than 250 pounds of fentanyl powder throughout the year...
Enero 26, 2023
PRESS RELEASE

DEA Washington Division Hosts 1st Family Summit to Engage with Families Affected by Fentanyl Poisoning

Noviembre 22, 2022
WASHINGTON, DC – The Drug Enforcement Administration (DEA) hosted regional family summits across the country in support of those who have lost loved ones to fentanyl poisoning. This is the first undertaking of its kind for the DEA field divisions and builds off the momentum of this summer’s Inaugural Family...
Noviembre 22, 2022
PRESS RELEASE

Sovah Health to Pay United States $4.36 Million to Settle Claims of Controlled Substance Act Violations

Junio 08, 2022
ABINGDON, Va. – Sovah Health has agreed to pay the United States $4.36 million to settle claims that the hospital system violated the Controlled Substances Act (CSA) on numerous occasions between 2017 and 2020. As part of the resolution, Sovah Health further agreed to be subject to a period of...
Junio 08, 2022
Showing 1 - 10 of 19 results

Paginación

  • Current page 1
  • Página 2
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster